Guillain-Barre syndrome occurring after adjuvant chemo-radiotherapy for endometrial cancer.

Autor(es): Tho L. M.; O'Leary C. P.; Horrocks I.; Al-Ani A.; Reed N. S.

Resumo: The association between Guillain-Barre syndrome (GBS) and malignancy is uncommon and has not been previously reported in gynecological cancers. Our case documents this syndrome occurring in a patient shortly after completion of adjuvant chemo-radiotherapy for endometrial carcinoma. We review the current literature and discuss potential pathogenic mechanisms of this likely paraneoplastic association. GBS in cancer patients is a potentially life-threatening condition and should be differentiated from simple chemotherapy toxicity, particularly as effective treatment is available.

Imprenta: Gynecologic Oncology, v. 100, n. 3, p. 615-617, 2006

Identificador do objeto digital: 10.1016/j.ygyno.2005.09.008

Descritores: Guillain-Barre Syndrome - Pathogenesis

Data de publicação: 2006